Attention Deficit-Hyperactivity Clinical Trial
— TDAHOfficial title:
Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition
The aim of this study is to analyse thanks to eye tracking experiments ocular movement
classical parameters in children with attention deficit hyperactivity (ADH) and to compare
them to results obtained in healthy children and to results obtained with neuropsychological
tests commonly used in standard health care.
We should then be able to compare eye tracking with neuropsychological parameters.
The final objective is to give to health professional a tool for ADH investigation with which
they should be able to do a simple and effective follow up of children with ADH.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 31, 2018 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 12 Years |
Eligibility |
Inclusion Criteria: - Children between 8 and 12 years old - Boys and girls - DSM-IV-TR diagnostic criteria for ADH - Children with methylprednisone treatment - Social security affiliation - signed informed consent Exclusion Criteria: - specialised scholarship - refusal from children or parents - too law results in WISC test (pre-inclusion test) |
Country | Name | City | State |
---|---|---|---|
France | Grenoble Alps Hospital | Grenoble |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble |
France,
Malsert J, Guyader N, Chauvin A, Polosan M, Szekely D, Bougerol T, Marendaz C. Saccadic performance and cortical excitability as trait-markers and state-markers in rapid cycling bipolar disorder: a two-case follow-up study. Front Psychiatry. 2013 Jan 4;3:112. doi: 10.3389/fpsyt.2012.00112. eCollection 2012. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Correlation between oculometric and neuropsychological tests in ADH evaluation | Differentiation between simple oculomotor disorder and attentional-visual disorder | Day 1 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03945175 -
Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening
|
Phase 3 | |
Completed |
NCT00205699 -
Metabolic Effects of Antipsychotics in Children
|
Phase 4 |